Therefore, a decrease in this genus may lead to changes in the immune response to the gut microbiota, promoting the upregulation of inflammatory factors IL-17 and TNF-α, further exacerbating the adverse effects related to the pathogenesis of psoriasis. This evidence concerns the gene IL17A and psoriasis.